Centellosides in Centella Asiatica: Bioconversion (Ratios), Elite Lines, Biomarkers
Abstract Centellosides viz., asiatic acid (ASA), madecassic acid (MDA), asiaticoside (ASI), madecassoside (MAD), are the major bioactive molecules in Centella asiatica (CA). In this study MDA:ASA, MAD:ASI (C6-hydroxylation versus non-hydroxylation) and ASI:ASA, MAD:MDA (C28-glycoside versus aglycone) ratios in 50 CA accessions originally collected from wild locations in south India and grown under identical ecological conditions for six generations were determined using validated HPTLC-densitometry protocol(s). ASA, MDA, ASI and MAD ranged from 0.01-0.29% (average 0.06 ± 0.08%, n = 22; 28 accessions recorded ASA content as zero), 0.02-0.72% (0.12 ± 0.13%), 0.04-2.41% (0.44 ± 0.52%) and 0.15%-5.27% (1.59 ± 1.26%, n = 50), respectively. Distinctly, C6-hydroxylated (MDA:ASA 4.00, MAD:ASI 3.61) and C28-glycosylated (ASI:ASA 7.33, MAD:MDA 13.25) centellosides dominated over the respective non-derivatized entities. Our results infer that both C6-hydroxylation by P450-dependent monooxygenases and C28-glycosylation by UDP-Glc glucosyltransferases (UGTs) are dominant biosynthetic steps in CA. This study also discovered six elite clones of CA from south India with their (ASI+MAD) contents above the industrial benchmark (≥ 4%). Two elite clones with ASI contents ≥ 2% were also identified. These elite lines can be multiplied and utilized for the industrial applications of CA. Besides, this study emphasizes the need for standardizing all four centellosides as biomarkers in CA raw drugs, pharmaceutical and cosmetic products.